» Articles » PMID: 34165263

Rehabilitation Interventions in Systemic Sclerosis: A Systematic Review and Future Directions

Overview
Specialty Rheumatology
Date 2021 Jun 24
PMID 34165263
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To systematically review evidence of rehabilitation interventions for improving outcomes in systemic sclerosis (SSc) and to evaluate evidence quality.

Methods: Several electronic databases were searched to identify studies in which rehabilitation professionals delivered, supervised, or participated in interventions for individuals with SSc. Randomized controlled trials (RCTs) or non-randomized trials, one-arm trials, and prospective quasi-experimental studies with interventions were included if they had ≥10 participants. Quality appraisal was conducted by 2 independent raters using the Physiotherapy Evidence Database (PEDro) Scale.

Results: A total of 16 good or excellent quality studies (15 RCTs, 1 prospective quasi-experimental study) were included. Most rehabilitation interventions focused on hands/upper extremities, followed by multicomponent, orofacial, and directed self-management. Sample sizes varied between 20-267 participants (median 38). In 50% of studies, participants in intervention groups significantly improved compared to controls. Most studies demonstrated within-group improvements in intervention groups. Interventions varied in content, delivery, length, and dose and outcome measures collected.

Conclusion: Existing evidence provides some support for rehabilitation in SSc, such as interventions that focus on hand and upper extremity outcomes or are multicomponent, although there is high study heterogeneity. The evidence base would benefit from interventions testing similar replicable components, use of common outcome measures, and incorporation of delivery modes that enable larger sample sizes. There are challenges in recruiting participants due to the rarity of SSc and high disease burden, as participants' involvement in rehabilitation studies requires active participation over time. Intervention studies designed to reduce participation barriers may facilitate translation of effective interventions into practice.

Citing Articles

Non-pharmacological rehabilitation interventions for individuals with antiphospholipid syndrome: A scoping review.

Harper A, Chen Y, Tancer S, Rodgers K, Crumb A, Townsend W Lupus. 2023; 33(2):101-110.

PMID: 38113856 PMC: 11003253. DOI: 10.1177/09612033231223336.


Experiences of Exergaming for Upper Extremity Exercises in People With Systemic Sclerosis.

Chen Y, Kruger G, Devine A, Khanna D, Murphy S OTJR (Thorofare N J). 2023; 43(4):665-675.

PMID: 37162267 PMC: 10527854. DOI: 10.1177/15394492231172934.


Perceived Cognitive Function in People With Systemic Sclerosis: Associations With Symptoms and Daily Life Functioning.

Chen Y, Lescoat A, Khanna D, Murphy S Arthritis Care Res (Hoboken). 2022; 75(8):1706-1714.

PMID: 35997486 PMC: 9947182. DOI: 10.1002/acr.25000.


Can home rehabilitation impact impulse oscillometry and lung ultrasound findings in patients with scleroderma-associated interstitial lung disease? A pilot study.

de Alegria S, Litrento P, Farias I, Mafort T, Lopes A BMC Res Notes. 2022; 15(1):176.

PMID: 35570301 PMC: 9107596. DOI: 10.1186/s13104-022-06064-6.

References
1.
Amiri M, Kumbhare D . Randomized controlled trials in non-pharmacological rehabilitation research: a scoping review of the reporting of sample size calculation, randomization procedure, and statistical analyses. Eur J Phys Rehabil Med. 2020; 56(6):790-798. DOI: 10.23736/S1973-9087.20.06451-5. View

2.
Whyte J, Dijkers M, Fasoli S, Ferraro M, Katz L, Norton S . Recommendations for Reporting on Rehabilitation Interventions. Am J Phys Med Rehabil. 2020; 100(1):5-16. DOI: 10.1097/PHM.0000000000001581. View

3.
Schouffoer A, Ninaber M, Beaart-van de Voorde L, van der Giesen F, de Jong Z, Stolk J . Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis. Arthritis Care Res (Hoboken). 2011; 63(6):909-17. DOI: 10.1002/acr.20448. View

4.
Sandusky S, McGuire L, Smith M, Wigley F, Haythornthwaite J . Fatigue: an overlooked determinant of physical function in scleroderma. Rheumatology (Oxford). 2008; 48(2):165-9. PMC: 2638541. DOI: 10.1093/rheumatology/ken455. View

5.
Poole J, Chandrasekaran A, Hildebrand K, Skipper B . Participation in life situations by persons with systemic sclerosis. Disabil Rehabil. 2014; 37(10):842-5. DOI: 10.3109/09638288.2014.944624. View